|
Post by sportsrancho on Apr 8, 2017 10:11:17 GMT -5
Doesn't matter, if he sees M&A potential he won't be the last:-) Fair enough, but at least understand he is betting next to nothing on it happening. Its not the same as half of this board who probably have half their portfolio in MNKD which we both know a lot do. I think its important for people to understand that. You play black jack at $10 a hand and he plays black jack at $100,000 a hand. Its all relative to your wealth. I just don't see it being about the amount. For whatever reason he decided to reduce his holdings in other stocks and add to MNKD says he sees it as undervalued at this price.
|
|
|
Post by gamblerjag on Apr 8, 2017 12:03:29 GMT -5
we know there are many reasons for an 8K. Here is a quick synopsis.
8k - Material event
What is an '8-K' An 8-K is a report of unscheduled material events or corporate changes at a company that could be of importance to the shareholders or the Securities and Exchange Commission (SEC). Also known as a Form 8-K, the report notifies the public of events reported including acquisition, bankruptcy, resignation of directors or a change in the fiscal year.
BREAKING DOWN '8-K' As opposed to the annual reporting of Form 10-K and the quarterly reporting of Form 10-Q, public companies utilize Form 8-K as needed. An 8-K is required to announce major events relevant to shareholders.
Cheds Breakdown:
8k can be a very powerful catalyst, or can be a big sell signal depending on what it says. This is the legit version of a PR, because an 8k has to be truthful and a CEO can not lie. If there is a reverse merger, you will see in the 8k, if there is a new toxic note taken out, you will see it in an 8k, and if there is a new CFO or CEO, you will see it in an 8k, etc.
|
|
|
Post by lakers on Apr 8, 2017 12:19:38 GMT -5
we know there are many reasons for an 8K. Here is a quick synopsis. 8k - Material event What is an '8-K' An 8-K is a report of unscheduled material events or corporate changes at a company that could be of importance to the shareholders or the Securities and Exchange Commission (SEC). Also known as a Form 8-K, the report notifies the public of events reported including acquisition, bankruptcy, resignation of directors or a change in the fiscal year. BREAKING DOWN '8-K' As opposed to the annual reporting of Form 10-K and the quarterly reporting of Form 10-Q, public companies utilize Form 8-K as needed. An 8-K is required to announce major events relevant to shareholders. Cheds Breakdown: 8k can be a very powerful catalyst, or can be a big sell signal depending on what it says. This is the legit version of a PR, because an 8k has to be truthful and a CEO can not lie. If there is a reverse merger, you will see in the 8k, if there is a new toxic note taken out, you will see it in an 8k, and if there is a new CFO or CEO, you will see it in an 8k, etc.
Chicago CBS 2 is the official Media partner. Hope they will provide an online video of the 4/8/2017 ADA event with interviews. Afrezza is listed as sponsor instead of the company Mannkind as opposed to Lilly, Novo. Is Afrezza going to be spun off as a separate company? Does it mean TS pipelines will be sold to RLS, Lily, Novo, Mylan, UTHR, CBD investors for at least $0.5B to finance Afrezza ? I prefer this so that we finally untangle from the starving vicious circle to properly commercialize, conduct trials for Afrezza for Ped, titration, time in range, UR labels. I always think Mnkd can't have it both ways and survive. It needs to sell TS pipelines for A to succeed. Mnkd can't nickel and dime, dink and dunk its way out of the perpetual starvation any longer. A needs at least 3 more years to succeed. See Matt's comparative chart. Thus it needs to be sufficiently financed, 0.5B - Notes. Is that why no additional share was proposed at 5/18 ASM in Danbury considering Mnkd has Notes due in a few months and runs out of cash this July? Mnkd said, Understandably, there are many parties who are waiting to see if Afrezza is adopted by the US and will be around. There are also many parties who want to be the first to introduce Afrezza in their regions. While there are ongoing discussions, our corporate policy is not to announce any material developments until there is definitive progress (translated to legally bounded agreements). Once potential international partners realize that A will be around for a foreseeable future, they will jump it with both feet. Success begets more success. Read more: mnkd.proboards.com/thread/7525/castagna-visit?page=2#ixzz4dgKNKNfh
|
|
|
Post by ilovekauai on Apr 8, 2017 12:36:38 GMT -5
Well Lakers, what you say here is plausible. I'm curious as to the timeline of all this possibly occurring? Are we talking next week, next month, June? Something has happened with that filing, but not sure exactly what. Mahalo for your post.
|
|
|
Post by nylefty on Apr 8, 2017 12:56:12 GMT -5
we know there are many reasons for an 8K. Here is a quick synopsis. Afrezza is listed as sponsor instead of the company Mannkind as opposed to Lilly, Novo. Is Afrezza going to be spun off as a separate company? Equal (the sugar substitute) is also listed as a sponsor but I don't think that means that Equal is going to be spun off by Merisant. MannKind has only one diabetes drug which is not the case with Lilly and Novo.
|
|
|
Post by kc on Apr 8, 2017 12:57:08 GMT -5
Well Lakers, what you say here is plausible. I'm curious as to the timeline of all this possibly occurring? Are we talking next week, next month, June? Something has happened with that filing, but not sure exactly what. Mahalo for your post. SAME BAT CHANNEL - SAME BAT TIME.....
|
|
|
Post by lakers on Apr 8, 2017 13:06:55 GMT -5
Afrezza is listed as sponsor instead of the company Mannkind as opposed to Lilly, Novo. Is Afrezza going to be spun off as a separate company? Equal (the sugar substitute) is also listed as a sponsor but I don't think that means that Equal is going to be spun off by Merisant. MannKind has only one diabetes drug which is not the case with Lilly and Novo. The Change of Control 8K filing clearly indicates a long term financial resolution is near. BoD know that they need a long term financial solution for A to succeed commercially and they have been searching for a long time.
|
|
|
Post by nylefty on Apr 8, 2017 13:31:20 GMT -5
Equal (the sugar substitute) is also listed as a sponsor but I don't think that means that Equal is going to be spun off by Merisant. MannKind has only one diabetes drug which is not the case with Lilly and Novo. The Change of Control 8K filing clearly indicates a long term financial resolution is near. BoD know that they need a long term financial solution for A to succeed commercially and they have been searching for a long time. From the "Form 10-Q, For the quarterly period ended June 30, 2014"
From "INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION"
Change of Control Agreements
We have entered into change of control agreements with Messrs. Edstrom and Pfeffer, and Drs. Martens and Thomson. Each agreement is for a period of two years and will be automatically renewed for additional one-year periods unless either party gives notice to terminate the agreement at least 90 days prior to the end of its initial term or any subsequent term.
Under the agreements, a change of control will be deemed to occur upon:
• any transaction that results in a person or group acquiring beneficial ownership of 50% or more of our voting stock, other than us, one of our employee benefit plans, Mr. Mann or any other entity in which Mr. Mann holds a majority of the beneficial interests;
• any merger, consolidation or reorganization of us in which our stockholders immediately prior to the transaction hold less than 50% of the voting power of the surviving entity following the transaction, subject to certain limitations;
• any transaction in which we sell all or substantially all of our assets, subject to certain limitations;
• our liquidation; or
• any reorganization of our Board of Directors in which our incumbent directors (as defined in the agreements) cease for any reason to constitute a majority of the members of our Board.
Read more: mnkd.proboards.com/thread/2190/change-control-agreements-bo-opportunities#ixzz4dgQvmcps
|
|
|
Post by kbrion77 on Apr 8, 2017 13:57:50 GMT -5
The Change of Control 8K filing clearly indicates a long term financial resolution is near. BoD know that they need a long term financial solution for A to succeed commercially and they have been searching for a long time. From the "Form 10-Q, For the quarterly period ended June 30, 2014"
From "INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION"
Change of Control Agreements
We have entered into change of control agreements with Messrs. Edstrom and Pfeffer, and Drs. Martens and Thomson. Each agreement is for a period of two years and will be automatically renewed for additional one-year periods unless either party gives notice to terminate the agreement at least 90 days prior to the end of its initial term or any subsequent term.
Under the agreements, a change of control will be deemed to occur upon:
• any transaction that results in a person or group acquiring beneficial ownership of 50% or more of our voting stock, other than us, one of our employee benefit plans, Mr. Mann or any other entity in which Mr. Mann holds a majority of the beneficial interests;
• any merger, consolidation or reorganization of us in which our stockholders immediately prior to the transaction hold less than 50% of the voting power of the surviving entity following the transaction, subject to certain limitations;
• any transaction in which we sell all or substantially all of our assets, subject to certain limitations;
• our liquidation; or
• any reorganization of our Board of Directors in which our incumbent directors (as defined in the agreements) cease for any reason to constitute a majority of the members of our Board.
Read more: mnkd.proboards.com/thread/2190/change-control-agreements-bo-opportunities#ixzz4dgQvmcpsYour move Lakers........
|
|
|
Post by gamblerjag on Apr 8, 2017 14:55:58 GMT -5
we know there are many reasons for an 8K. Here is a quick synopsis. 8k - Material event What is an '8-K' An 8-K is a report of unscheduled material events or corporate changes at a company that could be of importance to the shareholders or the Securities and Exchange Commission (SEC). Also known as a Form 8-K, the report notifies the public of events reported including acquisition, bankruptcy, resignation of directors or a change in the fiscal year. BREAKING DOWN '8-K' As opposed to the annual reporting of Form 10-K and the quarterly reporting of Form 10-Q, public companies utilize Form 8-K as needed. An 8-K is required to announce major events relevant to shareholders. Cheds Breakdown: 8k can be a very powerful catalyst, or can be a big sell signal depending on what it says. This is the legit version of a PR, because an 8k has to be truthful and a CEO can not lie. If there is a reverse merger, you will see in the 8k, if there is a new toxic note taken out, you will see it in an 8k, and if there is a new CFO or CEO, you will see it in an 8k, etc.
Chicago CBS 2 is the official Media partner. Hope they will provide an online video of the 4/8/2017 ADA event with interviews. Afrezza is listed as sponsor instead of the company Mannkind as opposed to Lilly, Novo. Is Afrezza going to be spun off as a separate company? Does it mean TS pipelines will be sold to RLS, Lily, Novo, Mylan, UTHR, CBD investors for at least $0.5B to finance Afrezza ? I prefer this so that we finally untangle from the starving vicious circle to properly commercialize, conduct trials for Afrezza for Ped, titration, time in range, UR labels. I always think Mnkd can't have it both ways and survive. It needs to sell TS pipelines for A to succeed. Mnkd can't nickel and dime, dink and dunk its way out of the perpetual starvation any longer. A needs at least 3 more years to succeed. See Matt's comparative chart. Thus it needs to be sufficiently financed, 0.5B - Notes. Is that why no additional share was proposed at 5/18 ASM in Danbury considering Mnkd has Notes due in a few months and runs out of cash this July? Mnkd said, Understandably, there are many parties who are waiting to see if Afrezza is adopted by the US and will be around. There are also many parties who want to be the first to introduce Afrezza in their regions. While there are ongoing discussions, our corporate policy is not to announce any material developments until there is definitive progress (translated to legally bounded agreements). Once potential international partners realize that A will be around for a foreseeable future, they will jump it with both feet. Success begets more success. Read more: mnkd.proboards.com/thread/7525/castagna-visit?page=2#ixzz4dgKNKNfhmany thought TecmospherIwas going to be the big moneymaker I sure hope they don't sell techno lakersabout for half billion to finance Rfrezza
|
|
|
Post by nylefty on Apr 8, 2017 16:22:17 GMT -5
|
|
|
Post by peppy on Apr 8, 2017 17:25:32 GMT -5
The Change of Control 8K filing clearly indicates a long term financial resolution is near. BoD know that they need a long term financial solution for A to succeed commercially and they have been searching for a long time. From the "Form 10-Q, For the quarterly period ended June 30, 2014"
From "INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION"
Change of Control Agreements
We have entered into change of control agreements with Messrs. Edstrom and Pfeffer, and Drs. Martens and Thomson. Each agreement is for a period of two years and will be automatically renewed for additional one-year periods unless either party gives notice to terminate the agreement at least 90 days prior to the end of its initial term or any subsequent term.
Under the agreements, a change of control will be deemed to occur upon:
• any transaction that results in a person or group acquiring beneficial ownership of 50% or more of our voting stock, other than us, one of our employee benefit plans, Mr. Mann or any other entity in which Mr. Mann holds a majority of the beneficial interests;
• any merger, consolidation or reorganization of us in which our stockholders immediately prior to the transaction hold less than 50% of the voting power of the surviving entity following the transaction, subject to certain limitations;
• any transaction in which we sell all or substantially all of our assets, subject to certain limitations;
• our liquidation; or
• any reorganization of our Board of Directors in which our incumbent directors (as defined in the agreements) cease for any reason to constitute a majority of the members of our Board.
Read more: mnkd.proboards.com/thread/2190/change-control-agreements-bo-opportunities#ixzz4dgQvmcpsSo it is one of these things plus: On April 6, 2017, MannKind Corporation (the “Company”) entered into a Change of Control Agreement with each of its executive officers (each, an “Executive”), consisting of: Matthew J. Pfeffer, Michael E. Castagna, David Thomson, Ph.D., J.D., Raymond Urbanski, M.D., Ph.D., Joseph Kocinsky, Rose Alinaya and Stuart A. Tross, Ph.D.
The Change of Control Agreement with each Executive provides for the employment of the Executive during the two-year period following a change of control of the Company and certain benefits during that period. Each Change of Control Agreement provides that during the two-year period following a change of control of the Company, the Executive will (i) have a position and duties commensurate to those of the Executive prior to the change of control, (ii) perform his or her services at the same work site as before the change of control, (iii) receive an annual base salary at least equal to the Executive’s annual base salary in effect during the year in which the change of control occurs, (iv) be eligible for an annual performance-based bonus equal to the average annual bonus paid or payable to the Executive for the three years prior to the change of control and (v) receive other benefits.
In addition, each Change of Control Agreement provides that in the event the Executive’s employment is terminated other than for cause or if the Executive resigns for good reason during the two-year period following a change of control of the Company (or prior to, but in anticipation of, a change of control of the Company), the Executive will be entitled to certain severance benefits,
We will find out on: ? Date: May 18, 2017 Time: 10:00 A.M. (Eastern Daylight Time) The annual shareholders meeting.
Are these the puzzle pieces? What are we looking at? What are the possibilities? Are these the only possibilities?
|
|
|
Post by derek2 on Apr 8, 2017 18:17:38 GMT -5
Let's review the actions of the week:
1. MNKD releases their proxy materials for the annual shareholders meeting, where people have the chance to oust the board and vote on management compensation (or to confirm both). 2. MNKD updates their change of control agreements to add their recent executive hires and give them a sweet golden parachute, so regardless of the outcome of #1, the gravy train continues. 3. MNKD updates their funnel, their regulatory dealings with the FDA, comments on sales effort and results.
Just joking about #3. If management has #2, why work on #3?
|
|
|
Post by sayhey24 on Apr 8, 2017 18:39:55 GMT -5
Options were issue on March 17 and expire in 60 days. Is that a coincidence, the day before the May 18 ASM? No vote to increase authorized shares. I sure hope the bagels are good this year. This could be the last trip to Danbury.
|
|
|
Post by peppy on Apr 8, 2017 19:01:07 GMT -5
Options were issue on March 17 and expire in 60 days. Is that a coincidence, the day before the May 18 ASM? No vote to increase authorized shares. I sure hope the bagels are good this year. This could be the last trip to Danbury. march 1, 2017 authorized 700,000,000 outstanding 478,637,095
1 for 5 authorized 140,000,000 outstanding 95,727,419
page 7
|
|